Pharmaceutical

Investment surges, hurdles and emerging innovations in neuroscience

Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in the field.

Nov 11, 2024 - 06:00
Investment surges, hurdles and emerging innovations in neuroscience
Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in the field.
Read the original article

Tags:

Previous Article

Dizal seeks FDA approval for NSCLC treatment sunvozertinib

Next Article

Pfizer considers divestiture of hospital drugs business

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Amgen ends two lupus programs; Illumina sequencers have security vulnerability

STAT+: Pharmalittle: Amgen ends two lupus programs; Ill...

Apr 29, 2023

STAT+: Pharmalittle: FDA approves over-the-counter Narcan; J&J exits the race for the first RSV vaccine

STAT+: Pharmalittle: FDA approves over-the-counter Narc...

Mar 30, 2023

Polio cases derived from new oral vaccine reported for first time

Polio cases derived from new oral vaccine reported for ...

Mar 19, 2023